On Sanofi's U.S. website, compare Influenza and Respiratory Syncytial Virus (RSV). For each, identify the primary affected population, the main protective measure highlighted, and the general impact/severity. Then, summarize the key differences in these descriptions.
Navigate to sanofi.com. Click on 'Your Health' in the main navigation menu. From the 'Your Health' dropdown, click on 'Vaccines'. Click on 'Influenza' to navigate to its information page. Extract the primary affected population, main protective measure, and general impact/severity for Influenza. Go back to the 'Vaccines' menu (or re-navigate via 'Your Health' -> 'Vaccines' if necessary). Click on 'Respiratory Syncytial Virus' to navigate to its information page. Extract the primary affected population, main protective measure, and general impact/severity for RSV. Synthesize and present a comparative summary of the information for both diseases.
Successfully navigate to both the 'Influenza' and 'Respiratory Syncytial Virus' pages on sanofi.com. For Influenza, state that it impacts 'people around the world,' the best protective measure is an 'annual flu vaccination,' and it leads to 'thousands of flu-related complications, hospitalizations, and deaths each year.' For Respiratory Syncytial Virus (RSV), state that it primarily targets 'babies,' emphasizes 'RSV prevention is awareness' and providing 'families... with resources and information' as protective measures, and causes 'serious lung infection.' Clearly present a comparative summary highlighting the differences in affected populations, protective measures, and general impact/severity for both diseases, based on the extracted information.